<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: The Four Greatest Risks of a Fraud or False Claims Act Suit against Pharmaceutical Companies</title>
	<atom:link href="http://www.corporatecomplianceinsights.com/2009/adulterated-drugs-medicaid-rebate-fraud-false-claims-act-risk-pharma-companies/feed" rel="self" type="application/rss+xml" />
	<link>http://www.corporatecomplianceinsights.com/2009/adulterated-drugs-medicaid-rebate-fraud-false-claims-act-risk-pharma-companies</link>
	<description>Corporate Compliance Insights is an online source for news and articles on topics related to governance, risk, and compliance.  CCI features daily GRC news updates plus feature articles from experienced GRC professionals.</description>
	<lastBuildDate>Fri, 12 Mar 2010 13:49:10 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.1</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	</channel>
</rss>
